- CEO
- Natalie Davis
- Full Time Employees
- 90,000
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 126 Phillip Street Sydney NSW Australia 2000
- IPO Date
- Jun 9, 2010
- Business
- Ramsay Health Care Limited (ASX:RHC; OTC:RMSYF) operates as a multinational private healthcare provider, owning and managing a global network of hospitals, day surgery facilities, primary care clinics, diagnostics centers, mental health services, rehabilitation units, community pharmacies, and at-home telehealth offerings. The company delivers integrated services encompassing surgical procedures including orthopaedics, cardiology, oncology, maternity, and general surgery; psychiatric care and residential mental health programs; rehabilitation and psychology outpatient treatments; imaging and diagnostic services; and specialized primary care such as cancer support, allied health, virtual monitoring, and community-based nursing. Founded in 1964 by Paul Ramsay in Sydney, Australia, where it maintains headquarters, Ramsay conducts operations across Australia, the United Kingdom, France, Indonesia, Malaysia, Denmark, and other European markets, serving millions of patients annually through over 400 facilities and employing more than 90,000 staff focused on high-quality clinical outcomes and research. In recent developments, Ramsay completed the acquisition of COSEM primary care clinics in France in June 2024, contributing significantly to revenue growth; announced a $190 million expansion of Joondalup Private Hospital in Western Australia including six new operating theatres and 82 beds set to open in early 2026 alongside a 15-year extension of its public-private partnership at Joondalup Health Campus to 2043; and advanced leadership initiatives through the Ramsay Australia Leadership Academy launched in late 2023 while partnering with Health Careers International and Arizona State University to address nursing workforce shortages. Natalie Davis serves as CEO-elect, succeeding Craig McNally in June 2025, amid ongoing investments in digital technologies, robotic surgery capabilities like MAKO systems and Da Vinci platforms, and innovative programs such as vaping cessation clinics and nurse-led cardiac implants.